XML 41 R31.htm IDEA: XBRL DOCUMENT
v3.22.2.2

CORRECTION OF PREVIOUSLY ISSUED QUARTERLY FINANCIAL INFORMATION | 12 Months Ended
--- | ---
Dec. 31, 2021
Accounting Changes and Error Corrections [Abstract] |
Correction of Previously Issued Quarterly Information | CORRECTION OF PREVIOUSLY ISSUED QUARTERLY FINANCIAL INFORMATION The following tables present the effect of correcting the Company’s previously issued quarterly financial statements for the accounting errors described in Note 1, Significant Accounting Policies and Restatement:
CONSOLIDATED STATEMENTS OF OPERATIONS
|  | Three Months Ended March 31, 2021 |  | Three Months Ended March 31, 2020
(in millions, except per share amounts) |  | As Previously Issued |  | Adjustment |  | As Revised |  | As Previously Issued |  | Adjustment |  | As Revised
Net sales |  | $ | 1,027 |  |  | $ | (1) |  |  | $ | 1,026 |  |  | $ | 874 |  |  | $ | 7 |  |  | $ | 881 |
Cost of products sold |  | 448 |  |  | (1) |  |  | 447 |  |  | 406 |  |  | — |  |  | 406 |
Gross profit |  | 579 |  |  | — |  |  | 579 |  |  | 468 |  |  | 7 |  |  | 475 |
Selling, general, and administrative expenses |  | 385 |  |  | 1 |  |  | 386 |  |  | 359 |  |  | (2) |  |  | 357 |
Research and development expenses |  | 37 |  |  | 3 |  |  | 40 |  |  | 34 |  |  | 2 |  |  | 36 |
Goodwill impairment |  | — |  |  | — |  |  | — |  |  | 157 |  |  | — |  |  | 157 |
Restructuring and other costs |  | 3 |  |  | — |  |  | 3 |  |  | 43 |  |  | (1) |  |  | 42 |
Operating income (loss) |  | 154 |  |  | (4) |  |  | 150 |  |  | (125) |  |  | 8 |  |  | (117) |
Other income and expenses: |  |  |  |  |  |  |  |  |  |  |  |
Interest expense, net |  | 14 |  |  | — |  |  | 14 |  |  | 7 |  |  | (1) |  |  | 6 |
Other expense (income), net |  | (9) |  |  | — |  |  | (9) |  |  | (2) |  |  | 1 |  |  | (1) |
Income (loss) before income taxes |  | 149 |  |  | (4) |  |  | 145 |  |  | (130) |  |  | 8 |  |  | (122) |
Provision for income taxes |  | 32 |  |  | 1 |  |  | 33 |  |  | 10 |  |  | 2 |  |  | 12 |
Net income (loss) |  | 117 |  |  | (5) |  |  | 112 |  |  | (140) |  |  | 6 |  |  | (134) |
Less: Net income (loss) attributable to noncontrolling interest |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Net income (loss) attributable to Dentsply Sirona |  | $ | 117 |  |  | $ | (5) |  |  | $ | 112 |  |  | $ | (140) |  |  | $ | 6 |  |  | $ | (134) |
Net income (loss) per common share attributable to Dentsply Sirona: |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | 0.53 |  |  | $ | (0.02) |  |  | $ | 0.51 |  |  | $ | (0.63) |  |  | $ | 0.02 |  |  | $ | (0.61) |
Diluted |  | $ | 0.53 |  |  | $ | (0.02) |  |  | $ | 0.51 |  |  | $ | (0.63) |  |  | $ | 0.02 |  |  | $ | (0.61) |
CONSOLIDATED STATEMENTS OF OPERATIONS
|  | Three Months Ended June 30, 2021 |  | Three Months Ended June 30, 2020
(in millions, except per share amounts) |  | As Previously Issued |  | Adjustment |  | As Revised |  | As Previously Issued |  | Adjustment |  | As Revised
Net sales |  | $ | 1,067 |  |  | $ | (5) |  |  | $ | 1,062 |  |  | $ | 491 |  |  | $ | 8 |  |  | $ | 499 |
Cost of products sold |  | 469 |  |  | (2) |  |  | 467 |  |  | 315 |  |  | 2 |  |  | 317 |
Gross profit |  | 598 |  |  | (3) |  |  | 595 |  |  | 176 |  |  | 6 |  |  | 182 |
Selling, general, and administrative expenses |  | 398 |  |  | (5) |  |  | 393 |  |  | 261 |  |  | (2) |  |  | 259 |
Research and development expenses |  | 40 |  |  | 3 |  |  | 43 |  |  | 18 |  |  | 2 |  |  | 20 |
Restructuring and other costs |  | 5 |  |  | — |  |  | 5 |  |  | 1 |  |  | 1 |  |  | 2 |
Operating income (loss) |  | 155 |  |  | (1) |  |  | 154 |  |  | (104) |  |  | 5 |  |  | (99) |
Other income and expenses: |  |  |  |  |  |  |  |  |  |  |  |
Interest expense, net |  | 16 |  |  | (1) |  |  | 15 |  |  | 11 |  |  | — |  |  | 11 |
Other expense (income), net |  | 5 |  |  | 3 |  |  | 8 |  |  | 5 |  |  | (1) |  |  | 4 |
Income (loss) before income taxes |  | 134 |  |  | (3) |  |  | 131 |  |  | (120) |  |  | 6 |  |  | (114) |
Provision (benefit) for income taxes |  | 35 |  |  | — |  |  | 35 |  |  | (24) |  |  | 2 |  |  | (22) |
Net income (loss) |  | 99 |  |  | (3) |  |  | 96 |  |  | (96) |  |  | 4 |  |  | (92) |
Less: Net income (loss) attributable to noncontrolling interest |  | — |  |  | — |  |  | — |  |  | (1) |  |  | — |  |  | (1) |
Net income (loss) attributable to Dentsply Sirona |  | $ | 99 |  |  | $ | (3) |  |  | $ | 96 |  |  | $ | (95) |  |  | $ | 4 |  |  | $ | (91) |
Net income (loss) per common share attributable to Dentsply Sirona: |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | 0.45 |  |  | $ | (0.01) |  |  | $ | 0.44 |  |  | $ | (0.44) |  |  | $ | 0.02 |  |  | $ | (0.42) |
Diluted |  | $ | 0.45 |  |  | $ | (0.02) |  |  | $ | 0.43 |  |  | $ | (0.44) |  |  | $ | 0.02 |  |  | $ | (0.42) |
CONSOLIDATED STATEMENTS OF OPERATIONS
|  | Three Months Ended September 30, 2021 |  | Three Months Ended September 30, 2020
(in millions, except per share amounts) |  | As Previously Issued |  | Adjustment |  | As Restated |  | As Previously Issued |  | Adjustment |  | As Revised
Net sales |  | $ | 1,069 |  |  | $ | (29) |  |  | $ | 1,040 |  |  | $ | 895 |  |  | $ | (12) |  |  | $ | 883 |
Cost of products sold |  | 478 |  |  | (7) |  |  | 471 |  |  | 453 |  |  | (2) |  |  | 451 |
Gross profit |  | 591 |  |  | (22) |  |  | 569 |  |  | 442 |  |  | (10) |  |  | 432 |
Selling, general, and administrative expenses |  | 394 |  |  | 1 |  |  | 395 |  |  | 315 |  |  | (2) |  |  | 313 |
Research and development expenses |  | 35 |  |  | 4 |  |  | 39 |  |  | 27 |  |  | 2 |  |  | 29 |
Restructuring and other costs |  | 3 |  |  | — |  |  | 3 |  |  | 18 |  |  | — |  |  | 18 |
Operating income |  | 159 |  |  | (27) |  |  | 132 |  |  | 82 |  |  | (10) |  |  | 72 |
Interest expense, net |  | 13 |  |  | 1 |  |  | 14 |  |  | 14 |  |  | — |  |  | 14 |
Other expense (income), net |  | 8 |  |  | (3) |  |  | 5 |  |  | 1 |  |  | — |  |  | 1 |
Income before income taxes |  | 138 |  |  | (25) |  |  | 113 |  |  | 67 |  |  | (10) |  |  | 57 |
Provision for income taxes |  | 35 |  |  | (6) |  |  | 29 |  |  | 13 |  |  | (4) |  |  | 9 |
Net income |  | 103 |  |  | (19) |  |  | 84 |  |  | 54 |  |  | (6) |  |  | 48 |
Net income attributable to Dentsply Sirona |  | $ | 103 |  |  | $ | (19) |  |  | $ | 84 |  |  | $ | 53 |  |  | $ | (6) |  |  | $ | 47 |
Net income per common share attributable to Dentsply Sirona: |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | 0.47 |  |  | $ | (0.08) |  |  | $ | 0.39 |  |  | $ | 0.25 |  |  | $ | (0.03) |  |  | $ | 0.22 |
Diluted |  | $ | 0.47 |  |  | $ | (0.09) |  |  | $ | 0.38 |  |  | $ | 0.25 |  |  | $ | (0.03) |  |  | $ | 0.22 |
CONSOLIDATED STATEMENTS OF OPERATIONS
|  | Three Months Ended December 31, 2021 |  | Three Months Ended December 31, 2020
(in millions, except per share amounts) |  | As Previously Issued |  | Adjustment |  | As Restated |  | As Previously Issued |  | Adjustment |  | As Revised
Net sales |  | $ | 1,088 |  |  | $ | 15 |  |  | $ | 1,103 |  |  | $ | 1,082 |  |  | $ | (6) |  |  | $ | 1,076 |
Cost of products sold |  | 495 |  |  | 4 |  |  | 499 |  |  | 511 |  |  | (2) |  |  | 509 |
Gross profit |  | 593 |  |  | 11 |  |  | 604 |  |  | 571 |  |  | (4) |  |  | 567 |
Selling, general, and administrative expenses |  | 374 |  |  | 3 |  |  | 377 |  |  | 377 |  |  | (4) |  |  | 373 |
Research and development expenses |  | 59 |  |  | (10) |  |  | 49 |  |  | 44 |  |  | (6) |  |  | 38 |
Restructuring and other costs |  | 6 |  |  | — |  |  | 6 |  |  | 15 |  |  | — |  |  | 15 |
Operating income |  | 154 |  |  | 18 |  |  | 172 |  |  | 135 |  |  | 6 |  |  | 141 |
Other income and expenses: |  |  |  |  |  |  |  |  |  |  |  |
Interest expense, net |  | 12 |  |  | — |  |  | 12 |  |  | 15 |  |  | — |  |  | 15 |
Other expense (income), net |  | 4 |  |  | — |  |  | 4 |  |  | (3) |  |  | — |  |  | (3) |
Income before income taxes |  | 138 |  |  | 18 |  |  | 156 |  |  | 123 |  |  | 6 |  |  | 129 |
Provision for income taxes |  | 36 |  |  | 1 |  |  | 37 |  |  | 24 |  |  | — |  |  | 24 |
Net income |  | 102 |  |  | 17 |  |  | 119 |  |  | 99 |  |  | 6 |  |  | 105 |
Less: Net income attributable to noncontrolling interest |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Net income attributable to Dentsply Sirona |  | $ | 102 |  |  | $ | 17 |  |  | $ | 119 |  |  | $ | 99 |  |  | $ | 6 |  |  | $ | 105 |
Net income per common share attributable to Dentsply Sirona: |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | 0.47 |  |  | $ | 0.08 |  |  | $ | 0.55 |  |  | $ | 0.45 |  |  | $ | 0.03 |  |  | $ | 0.48 |
Diluted |  | $ | 0.47 |  |  | $ | 0.07 |  |  | $ | 0.54 |  |  | $ | 0.45 |  |  | $ | 0.03 |  |  | $ | 0.48 |
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
| Three Months Ended March 31, 2021 |  | Three Months Ended March 31, 2020
(in millions) | As Previously Issued |  | Adjustment |  | As Revised |  | As Previously Issued |  | Adjustment |  | As Revised
Net income (loss) | $ | 117 |  |  | $ | (5) |  |  | $ | 112 |  |  | $ | (140) |  |  | $ | 6 |  |  | $ | (134) |
Total comprehensive income | 27 |  |  | (5) |  |  | 22 |  |  | (252) |  |  | 6 |  |  | (246) |
Comprehensive income attributable to Dentsply Sirona | $ | 27 |  |  | $ | (5) |  |  | $ | 22 |  |  | $ | (252) |  |  | $ | 6 |  |  | $ | (246) |
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
| Three Months Ended June 30, 2021 |  | Three Months Ended June 30, 2020
(in millions) | As Previously Issued |  | Adjustment |  | As Revised |  | As Previously Issued |  | Adjustment |  | As Revised
Net income (loss) | $ | 99 |  |  | $ | (3) |  |  | $ | 96 |  |  | $ | (96) |  |  | $ | 4 |  |  | $ | (92) |
Total comprehensive income | 142 |  |  | (3) |  |  | 139 |  |  | (28) |  |  | 4 |  |  | (24) |
Comprehensive income attributable to Dentsply Sirona | $ | 142 |  |  | $ | (3) |  |  | $ | 139 |  |  | $ | (28) |  |  | $ | 4 |  |  | $ | (24) |
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
|  | Three Months Ended September 30, 2021 |  | Three Months Ended September 30, 2020
(in millions) |  | As Previously Issued |  | Adjustment |  | As Restated |  | As Previously Issued |  | Adjustment |  | As Revised
Net income |  | $ | 103 |  |  | $ | (19) |  |  | $ | 84 |  |  | $ | 54 |  |  | $ | (6) |  |  | $ | 48 |
Total comprehensive income |  | 47 |  |  | (19) |  |  | 28 |  |  | 121 |  |  | (6) |  |  | 115 |
Comprehensive income attributable to Dentsply Sirona |  | $ | 47 |  |  | $ | (19) |  |  | $ | 28 |  |  | $ | 121 |  |  | $ | (6) |  |  | $ | 115 |
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
| Three Months Ended December 31, 2021 |  | Three Months Ended December 31, 2020
(in millions) | As Previously Issued |  | Adjustment |  | As Restated |  | As Previously Issued |  | Adjustment |  | As Revised
Net income (loss) | $ | 102 |  |  | $ | 17 |  |  | $ | 119 |  |  | $ | 99 |  |  | $ | 6 |  |  | $ | 105 |
Total comprehensive income | 75 |  |  | 17 |  |  | 92 |  |  | 213 |  |  | 8 |  |  | 221 |
Comprehensive income attributable to Dentsply Sirona | $ | 75 |  |  | $ | 17 |  |  | $ | 92 |  |  | $ | 213 |  |  | $ | 8 |  |  | $ | 221 |
The correcting of these accounting errors on the Company’s previously issued Consolidated Statement of Cash Flows resulted in no changes to cash used in or provided by Operating, Investing and Financing activities for the quarterly periods of the year ended December 31, 2021. For the three months ended March 31, 2020, six months ended June 30, 2020 and nine months ended September 30, 2020 cash provided by operating activities and used in financing activities were increased by $6 million, $12 million, and $13 million, respectively.
QUARTERLY FINANCIAL INFORMATION (UNAUDITED) |
2021 |  | Net Sales |  | Gross Profit |  |  |  | Operating Income (Loss) |  | Net (Loss) Income attributable to Dentsply Sirona |  | Net (Loss) Income per Common Share - Basic |  | Net (Loss) Income per Common Share - Diluted |  | Cash Dividends Declared per Common Share
First Quarter |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
As previously issued |  | $ | 1,027 |  |  | $ | 579 |  |  |  |  | $ | 154 |  |  | $ | 117 |  |  | $ | 0.53 |  |  | $ | 0.53 |  |  | $ | 0.1000 |
Adjustment |  | (1) |  |  | — |  |  |  |  | (4) |  |  | (5) |  |  | (0.02) |  |  | (0.02) |  |  | — |
As revised |  | $ | 1,026 |  |  | $ | 579 |  |  |  |  | $ | 150 |  |  | $ | 112 |  |  | $ | 0.51 |  |  | $ | 0.51 |  |  | $ | 0.1000 |
Second Quarter |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
As previously issued |  | $ | 1,067 |  |  | $ | 598 |  |  |  |  | $ | 155 |  |  | $ | 99 |  |  | $ | 0.45 |  |  | $ | 0.45 |  |  | $ | 0.1100 |
Adjustment |  | (5) |  |  | (3) |  |  |  |  | (1) |  |  | (3) |  |  | (0.01) |  |  | (0.02) |  |  | — |
As revised |  | $ | 1,062 |  |  | $ | 595 |  |  |  |  | $ | 154 |  |  | $ | 96 |  |  | $ | 0.44 |  |  | $ | 0.43 |  |  | $ | 0.1100 |
Third Quarter |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
As previously issued |  | $ | 1,069 |  |  | $ | 591 |  |  |  |  | $ | 159 |  |  | $ | 103 |  |  | $ | 0.47 |  |  | $ | 0.47 |  |  | $ | 0.1100 |
Adjustment |  | (29) |  |  | (22) |  |  |  |  | (27) |  |  | (19) |  |  | (0.08) |  |  | (0.09) |  |  | — |
As restated |  | $ | 1,040 |  |  | $ | 569 |  |  |  |  | $ | 132 |  |  | $ | 84 |  |  | $ | 0.39 |  |  | $ | 0.38 |  |  | $ | 0.1100 |
Fourth Quarter |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
As previously issued |  | $ | 1,088 |  |  | $ | 593 |  |  |  |  | $ | 154 |  |  | $ | 102 |  |  | $ | 0.47 |  |  | $ | 0.47 |  |  | $ | 0.1100 |
Adjustment |  | 15 |  |  | 11 |  |  |  |  | 18 |  |  | 17 |  |  | 0.08 |  |  | 0.07 |  |  | — |
As restated |  | $ | 1,103 |  |  | $ | 604 |  |  |  |  | $ | 172 |  |  | $ | 119 |  |  | $ | 0.55 |  |  | $ | 0.54 |  |  | $ | 0.1100 |
Rounding, As previously issued |  | — |  |  | — |  |  |  |  | — |  |  | — |  |  | 0.01 |  |  | (0.01) |  |  | — |
Rounding: Adjustment |  | — |  |  | — |  |  |  |  | — |  |  | — |  |  | (0.02) |  |  | 0.02 |  |  | — |
Rounding, As revised |  | — |  |  | — |  |  |  |  | — |  |  | — |  |  | (0.01) |  |  | 0.01 |  |  | — |
Total Year |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
As previously issued |  | $ | 4,251 |  |  | $ | 2,361 |  |  |  |  | $ | 622 |  |  | $ | 421 |  |  | $ | 1.93 |  |  | $ | 1.91 |  |  | $ | 0.4300 |
Adjustment |  | (20) |  |  | (14) |  |  |  |  | (14) |  |  | (10) |  |  | (0.05) |  |  | (0.04) |  |  | — |
As revised |  | $ | 4,231 |  |  | $ | 2,347 |  |  |  |  | $ | 608 |  |  | $ | 411 |  |  | $ | 1.88 |  |  | $ | 1.87 |  |  | $ | 0.4300 |
2020 |  | Net Sales |  | Gross Profit |  |  |  | Operating Income (Loss) |  | Net (Loss) Income attributable to Dentsply Sirona |  | Net (Loss) Income per Common Share - Basic |  | Net (Loss) Income per Common Share - Diluted |  | Cash Dividends Declared per Common Share
First Quarter |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
As previously issued |  | $ | 874 |  |  | $ | 468 |  |  |  |  | $ | (125) |  |  | $ | (140) |  |  | $ | (0.63) |  |  | $ | (0.63) |  |  | $ | 0.1000 |
Adjustment |  | 7 |  |  | 7 |  |  |  |  | 8 |  |  | 6 |  |  | 0.02 |  |  | 0.02 |  |  | — |
As revised |  | $ | 881 |  |  | $ | 475 |  |  |  |  | $ | (117) |  |  | $ | (134) |  |  | $ | (0.61) |  |  | $ | (0.61) |  |  | $ | 0.1000 |
Second Quarter |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
As previously issued |  | $ | 491 |  |  | $ | 176 |  |  |  |  | $ | (104) |  |  | $ | (95) |  |  | $ | (0.44) |  |  | $ | (0.44) |  |  | $ | 0.1000 |
Adjustment |  | 8 |  |  | 6 |  |  |  |  | 5 |  |  | 4 |  |  | 0.02 |  |  | 0.02 |  |  | — |
As revised |  | $ | 499 |  |  | $ | 182 |  |  |  |  | $ | (99) |  |  | $ | (91) |  |  | $ | (0.42) |  |  | $ | (0.42) |  |  | $ | 0.1000 |
Third Quarter |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
As previously issued |  | $ | 895 |  |  | $ | 442 |  |  |  |  | $ | 82 |  |  | $ | 53 |  |  | $ | 0.25 |  |  | $ | 0.25 |  |  | $ | 0.1000 |
Adjustment |  | (12) |  |  | (10) |  |  |  |  | (10) |  |  | (6) |  |  | (0.03) |  |  | (0.03) |  |  | — |
As revised |  | $ | 883 |  |  | $ | 432 |  |  |  |  | $ | 72 |  |  | $ | 47 |  |  | $ | 0.22 |  |  | $ | 0.22 |  |  | $ | 0.1000 |
Fourth Quarter |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
As previously issued |  | $ | 1,082 |  |  | $ | 571 |  |  |  |  | $ | 135 |  |  | $ | 99 |  |  | $ | 0.45 |  |  | $ | 0.45 |  |  | $ | 0.1000 |
Adjustment |  | (6) |  |  | (4) |  |  |  |  | 6 |  |  | 6 |  |  | 0.03 |  |  | 0.03 |  |  | — |
As revised |  | $ | 1,076 |  |  | $ | 567 |  |  |  |  | $ | 141 |  |  | $ | 105 |  |  | $ | 0.48 |  |  | $ | 0.48 |  |  | $ | 0.1000 |
Rounding, As previously issued |  | — |  |  | — |  |  |  |  | — |  |  | — |  |  | (0.01) |  |  | (0.01) |  |  | — |
Rounding, Adjustment |  | — |  |  | — |  |  |  |  | — |  |  | — |  |  | 0.01 |  |  | 0.01 |  |  | — |
Total Year |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
As previously issued |  | $ | 3,342 |  |  | $ | 1,657 |  |  |  |  | $ | (12) |  |  | $ | (83) |  |  | $ | (0.38) |  |  | $ | (0.38) |  |  | $ | 0.4000 |
Adjustment |  | (3) |  |  | (1) |  |  |  |  | 9 |  |  | 10 |  |  | 0.05 |  |  | 0.05 |  |  | — |
As revised |  | $ | 3,339 |  |  | $ | 1,656 |  |  |  |  | $ | (3) |  |  | $ | (73) |  |  | $ | (0.33) |  |  | $ | (0.33) |  |  | $ | 0.4000 |

X
- References No definition available. + Details
Name: | us-gaap_AccountingChangesAndErrorCorrectionsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting error correction. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 7 -URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794 + Details
Name: | us-gaap_ErrorCorrectionTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -URI http://asc.fasb.org/topic&trid=2126967 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 50 -Paragraph 1B -URI http://asc.fasb.org/extlink&oid=124502072&loc=SL124452896-108306 + Details
Name: | us-gaap_QuarterlyFinancialInformationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration